NOVOZYMES A/S: cash_and_equivalents

Value{"amount": 139700000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2022-12-31)
Statussuperseded
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2024-12-31
Retrieved: 2026-08-23T23:26:08.487466+02:00
Raw response sha256: 301aba67a87c48da0199cce07c6e3a22…
Cite as: FACTANKER, https://factanker.com/fact/fdcd050b-4745-4853-b747-e77d72d1fd67

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies